Michael J. LaBarre insider trades
Open-market stock purchases and sales by Michael J. LaBarre, SVP, CHIEF TECHNICAL OFFICER at Halozyme Therapeutics, Inc, from SEC Form 4 filings since Feb 3, 2011.
Recent trades
No open-market trades in the last 12 months.
Companies traded
- HALO Halozyme Therapeutics, Inc: 70 sales, last Feb 27, 2025